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The expression plasmid containing human prepro-endothelin cDNA was constructed and introduced into COS-7 cells. 
Mature endothelin, consisting of 21 amino acid residues, was secreted into the culture medium of the transfected cells 
and was also synthesized by non-transfected COS-7 cells. Normal kidney cells derived from other species also synthesized 
and secreted endothelins. Partial characterization of endothelins produced by kidney cells suggested the existence of new 
types of endothelin. This is the first report of the vasoconstrictor peptide endothelin being synthesized in kidney cells. 
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1. INTRODUCTION 
The vasoconstrictor peptide endothelin has been 
obtained from the culture medium of porcine aor- 
tic endothelial cells and its structure, the nucleotide 
sequence of the cloned cDNA, determined [11. We 
have also succeeded in cloning the human prepro- 
endothelin cDNA, and identified the amino acid 
sequences of human and porcine endothelin [2]. 
Recently, the amino acid sequences of two other 
types of human endothelin were deduced by se- 
quencing of the cloned human genomic DNAs and 
termed endothelin 2 and 3 (ET-2 and -3) [3]. 
However, these types of endothelin have not yet 
been detected in any cells, tissues, or organs. Also, 
the precise mechanisms of processing endothelin 
from prepro-endothelin, consisting of 212 amino 
acids, remain unknown. We thus attempted to ex- 
press the cDNA encoding the human prepro- 
endothelin in mammalian cells in order to deter- 
mine the processing steps, and found that matured, 
processed endothelin 1 (ET-l) was secreted in the 
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culture medium of COS-7 cells. We also observed 
that normal kidney cells from other species syn- 
thesized and secreted endothelins. We report here 
on the synthesis and secretion of endothelin by 
kidney cells and their partial characterization. 
2. MATERIALS AND METHODS 
2.1. Materials 
DEAE-Dextran (MI 500000, n = 0.5) was obtained from 
Pharmacia; Sep-Pak Cl8 cartridge from Waters Associates 
(MA); Dulbecco’s and Earle’s minimum essential medium 
(DMEM, EMEM) from Flow Labs, fetal calf serum (FCS) from 
Microbiological Co.; restriction enzymes from Takara Shuzo 
Co.; and T4 DNA ligase and BgnI linkers from New England 
Biolabs. 
2.2. Cells and cell culture 
COS-7 cells and other kidney cell lines were obtained from the 
American Tissue Culture Collection (ATCC) and cultured in 
DMEM or EMEM containing 10% FCS, glutamine (0.3 
mg/ml), penicillin (SO U/ml), and streptomycin (0.05 mg/ml) in 
a humidified atmosphere of 5% COa/95% air at 37°C. 
2.3. Construction of expression plasmid and cell 
transformation 
DNA modification, ligation and transformation were carried 
out as described by Maniatis et al. [4]. The plasmid with human 
endothelin cDNA, pHET 4-3, and expression plasmid for 
animal cells, pTB551, were used. 
Plasmid pHET 4-3 was digested with the restriction enzyme 
EcoRI and a 1.17 kb cDNA fragment was obtained. After T4 
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DNA polymerase reaction to fill the single-stranded portion, the 
BglII linker d(GAAGATCTTC) was ligated and the BgnI frag- 
ment containing the coding region of prepro-endothelin was in- 
serted into the Bg/II sites of pTB551 to obtain pTS6003 as 
shown in fig. 1. DNA transfection was performed with DEAE- 
dextran as in 151. 
2.4. High-performance liquid chromatography (HPLC) of the 
culture medium 
The culture medium of COS-7 cells was recovered 5 days after 
confluence, acidified with acetic acid to a final concentration of 
3% and concentrated using the Sep-Pak Cl8 cartridge as 
described [6]. The eluted material in 4 ml acetic acid/etha- 
nol/HzO (4: 86: 10) was dried under a stream of NZ and resolved 
with 250~1 of 60% acetonitrile containing 0.05% trifluoroacetic 
acid (TFA). The preparation was then applied to a TSK ODS-80 
column (4.6 x 250 mm, Tosoh, Japan). During elution, the 
concentration of acetonitrile containing 0.05% TFA was 
elevated linearly from 0 to 27% over 5 min, from 27 to 43.5% 
over 20 min, and finally from 43.5 to 60% over 5 min at a flow 
rate of 1 ml/min. Each separated preparation was lyophilized 
and assayed for endothelin by sandwich-EIA. 
2.5. Enzyme immunoassay (EIA) 
The culture media of the kidney cells and the preparations 
separated by HPLC were assayed for endothelin as described 
elsewhere [6]. 
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Fig. 1. Construction of human endothelin expression plasmid of 
animal cells. The Bg/II fragment coding for human prepro- 
endothelin was inserted into the BgflI sites of pTB551 to obtain 
pTS6003. 
3. RESULTS AND DISCUSSION 
3.1. Synthesis and secretion of endothelin by 
CO9 7 cells 
The sensitivity of the EIA that we developed for 
endothelin is very high; for example, 2 pg/ml of en- 
dothelin can be detected in this [l-21] assay system. 
Thus, this method is useful for detecting en- 
dothelin without the need to concentrate prepara- 
tions. With this assay system, we confirmed that 
COS-7 cells transfected with the expression plas- 
mid containing human prepro-endothelin cDNA 
could synthesize and secrete mature endothelin in 
the culture medium at about 650 pg/ml after 96 h 
culture (to appear elsewhere). 
These transfection experiments howed that non- 
transfected COS-7 cells secreted immunoreactive 
endothelin into the culture medium. The fact that 
endothelin, which was first found in the culture 
medium of endothelial cells of the vein, was also 
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Fig.2. Titration of endothelin in concentrated culture medium 
of COS-7 cells. Culture medium (10 ml obtained 96 h after the 
confluent state of COS-7 cells) was concentrated to 0.3 ml with 
Sep-Pak and diluted with buffer for sandwich EIA and assayed. 
Values are means (n = 2). (w) Cultured medium of COS-7 
cells, (W) medium. 
43 
Volume 249, number 1 FEBS LETTERS May 1989 
synthesized in the kidney cells suggests that there 
may be other endothelin-producing organs or 
tissues. To characterize the immunoreactive en- 
dothelins produced by non-transfected COS-7 
cells, the culture media from both plasmid 
pTS6003-transfected and non-transfected COS-7 
cells were subjected to adsorption experiments with 
anti-whole endothelin antibodies (AwETN40 an- 
tibody) coupled with Sepharose 4B. The immuno- 
reactive endothelins were completely adsorbed on 
beads coated with AwETN40 antibodies (not 
shown). These results suggested that the immuno- 
reactive endothelin produced by COS-7 cells had 
the same antigenic determinant as the expression 
product of plasmid pTS6003. To confirm further 
the secretion of immunoreactive ndothelin from 
COS-7 cells and to eliminate possible contamina- 
tion of endothelin from the FCS used in cell 
culture, the culture medium of COS-7 cells and 
medium containing 10% FCS were concentrated 
with Sep-Pak, diluted l/4 serially and assayed. As 
shown in fig.2, immunoreactive endothelin was 
clearly detected in the concentrated culture 
medium of COS-7 cells and the contents decreased 
with sample dilution. No immunoreactive en- 
dothelin was detected in the medium for the COS-7 
cells. This result suggested that non-transfected 
COS-7 cells secreted the endothelin in the cultured 
medium. 
3.2. Synthesis of immunoreactive ndothelin in 
other kidney cells 
As the COS-7 cell is one of the SV40 transformed 
cells, we examined other normal kidney cells to 
determine whether they synthesize endothelin. 
Some kidney cell lines from monkey, dog, rabbit, 
rat and hamster were cultured in Falcon dishes with 
EMEM or DMEM and culture media from these 
cells were used for EIA of endothelin. As expected, 
and shown in table 1, monkey kidney CV-1 cells, 
which are the original normal kidney cells from 
African green monkey, and Vero cells synthesized 
immunoreactive endothelin. MDCK, RK-13, 
NRK-52 and BHK-21 cells also synthesized im- 
munoreactive endothelin. The quantities of en- 
dothelin produced in these kidney cell lines were 
about l/l OO- 1 / 10th of that of porcine aortic endo- 
thelial cells (PAE) used as a control cell line, 
however the endothelin was clearly produced not 
only in endothelial cells but also in kidney cells. 
Support for these results came from the finding 
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Table 1 
Synthesis of immunoreactive endothelin by cultured kidney cell 
lines 
Cell lines Total amount of pg endothelin 
endothelin (pg) produced/lO’ 
cells per 2 days 
Monkey 
cos-7 
cv-1 
Vero 
4860 f 620b 1310 f 150 
5100 f 690 2460 rt 440 
625 + 40 554 + 25 
Dog 
MDCK 3560 +z 930 1115 f 180 
Rabbit 
RK-13 1440’ 240 
Rat 
NRK-52E 1580 530 
Hamster 
BHK-21 540 110 
Pig AE’ 17550 14630 
a Porcine aortic endothelial cells prepared by the method of 
Neich et al. [lo] 
b Mean + SD (n = 3) 
’ Mean (n = 2) 
Kidney cells from monkey, dog, rat, rabbit, and hamster were 
cultured in 5 ml DMEM or EMEM supplemented with 10% 
FCS. 2 days after reaching confluence for each cell line, culture 
media were harvested and used for EIA of endothelin. Cell 
numbers were counted with a hemocytometer 
that primary cultured cells of rat kidney also 
secreted immunoreactive ndothelin (not shown). 
We have also detected endothelins in tissue extracts 
of kidney, lung and brain of rat (to be published). 
3.3. Properties of immunoreactive endothelin 
produced by COS-7 cells 
To characterize the immunoreactive ndothelin 
produced by COS-7 cells, culture medium was con- 
centrated and subjected to HPLC as described 
above. The control, chemically synthesized en- 
dothelins ET-l and ET-2 were also subjected to 
HPLC and their elution profiles compared. As 
shown in fig.3, immunoreactive ndothelin eluted 
in fractions 23-24 and 25-26. As the capacity of 
HPLC for separating small peptides such as en- 
dothelin is believed to be adequate, this broad pat- 
tern suggested the existence of other immunoreac- 
tive materials without mature endothelin. When 
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Fig.3. HPLC elution profile of immunoreactive ndothelin 
from concentrated culture medium of COS-7 cells. Culture 
medium of COS-7 cells (1.3 1) was concentrated as described in 
Section 2 and 1.5 ml of the resolved preparation in 60% CHsCN 
containing 0.05% TFA was applied to a TSK DS-80 column, 
eluted and then dried. A l/40 volume from each fraction was us- 
ed for EIA of endothelin. The immunoreactive ndothelin con- 
tents were calculated as the original volume. 
the material eluting in fractions 23-24 was rechro- 
matographed on a TSK ODS-80 TM column with 
34% CH&N containing 0.05% TFA, two main 
peaks appeared at fractions 3 and 6, respectively 
(fig.4A). Fractions 25-26 in fig.3 were 
rechromatographed under the above conditions, 
resulting in the major peak appearing in fraction 6 
(fig.4B) which was the same as the second peak that 
appeared on rechromatography in fig.4A. The 
peak fraction, nos 23-24 in fig.3, coincided with 
the position of chemically synthesized ET-l, 
however, immunoreactive endothelin in fractions 
25-26 in fig.3 and fraction 6 in fig.4B were com- 
pletely different from ET-l, although close to the 
position of ET-2. These experimental results sug- 
gested that COS-7 cells synthesized the vasocon- 
strictor peptide endothelin and secreted it into the 
culture medium. The mature form of the poly- 
peptide comprised 21 amino acid residues. Another 
immunoreactive endothelin which might be of a 
different type was recently reported by others [3]. 
These results suggest hat endothelin, which was 
first observed in endothelial cells, might be pro- 
duced in other organs such as kidney or lung. We 
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Fig.4. Second HPLC elution profiles of the immunoreactive n- 
dothelin. The preparations in fractions 23-24 and 25-26 in fig.3 
were rechromatographed on HPLC and eluted with non- 
gradient solvent (34% CH&N containing 0.05% TFA), dried 
and assayed. (A) Rechromatographed fractions 23-24, (B) frac- 
tions 25-26. 
have already found that immunoreactive endo- 
thelin was produced in primary cultured cells from 
rat lung. Endothelin has also been reported to in- 
hibit the release of renin from juxtaglomerular cells 
in the kidney [8] and to induce contraction of the 
45 
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trachea in guinea pig lung [9]. We therefore con- 
elude that endothelin seems to play important 
physiological roles locally in the kidney, lung, and 
other organs with vasoconstrictor and other ac- 
tivities .
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